Versant Capital Management’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $50.2K | Buy |
313
+65
| +26% | +$10.8K | ﹤0.01% | 1401 |
|
|
2026
Q2 | $36.4K | Sell |
248
-399
| -62% | -$52K | ﹤0.01% | 1588 |
|
|
2026
Q1 | $83.6K | Sell |
647
-156
| -19% | -$22.4K | 0.01% | 956 |
|
|
2025
Q4 | $115K | Buy |
803
+447
| +126% | +$59.9K | 0.01% | 700 |
|
|
2025
Q3 | $42.7K | Sell |
356
-59
| -14% | -$7.48K | 0.01% | 1122 |
|
|
2025
Q2 | $54.8K | Buy |
415
+250
| +152% | +$33.9K | 0.01% | 945 |
|
|
2025
Q1 | $22.9K | Sell |
165
-81
| -33% | -$12.6K | ﹤0.01% | 1272 |
|
|
2024
Q4 | $38.2K | Hold |
246
| – | – | 0.01% | 689 |
|
|
2024
Q3 | $44.8K | Buy |
246
+89
| +57% | +$13.2K | 0.01% | 500 |
|
|
2024
Q2 | $18.6K | Buy |
157
+105
| +202% | +$11K | ﹤0.01% | 751 |
|
|
2024
Q1 | $5.58K | Buy |
52
+48
| +1,200% | +$4.77K | ﹤0.01% | 983 |
|
|
2023
Q4 | $399 | Sell |
4
-4
| -50% | -$391 | ﹤0.01% | 1727 |
|
|
2023
Q3 | $952 | Buy |
8
+4
| +100% | +$597 | ﹤0.01% | 1541 |
|
|
2023
Q2 | $713 | Hold |
4
| – | – | ﹤0.01% | 1723 |
|
|
2023
Q1 | $660 | Hold |
4
| – | – | ﹤0.01% | 1543 |
|
|
2022
Q4 | $630 | Hold |
4
| – | – | ﹤0.01% | 1402 |
|
|
2022
Q3 | $1K | Sell |
4
-3
| -43% | -$499 | ﹤0.01% | 1254 |
|
|
2022
Q2 | $1K | Hold |
7
| – | – | ﹤0.01% | 1274 |
|
|
2022
Q1 | $2K | Hold |
7
| – | – | ﹤0.01% | 1138 |
|
|
2021
Q4 | $2K | Hold |
7
| – | – | ﹤0.01% | 1131 |
|
|
2021
Q3 | $2K | Hold |
7
| – | – | ﹤0.01% | 1130 |
|
|
2021
Q2 | $1K | Hold |
7
| – | – | ﹤0.01% | 1284 |
|
|
2021
Q1 | $1K | Hold |
7
| – | – | ﹤0.01% | 1368 |
|
|
2020
Q4 | $1K | Hold |
7
| – | – | ﹤0.01% | 1220 |
|
|
2020
Q3 | $1K | Hold |
7
| – | – | ﹤0.01% | 1182 |
|
|
2020
Q2 | $1K | Sell |
7
-7
| -50% | -$1.39K | ﹤0.01% | 1176 |
|
|
2020
Q1 | $2K | Sell |
14
-39
| -74% | -$7.51K | ﹤0.01% | 1009 |
|
|
2019
Q4 | $9K | Sell |
53
-9
| -15% | -$1.55K | ﹤0.01% | 731 |
|
|
2019
Q3 | $9K | Buy |
62
+6
| +11% | +$1.19K | ﹤0.01% | 752 |
|
|
2019
Q2 | $14K | Sell |
56
-54
| -49% | -$12.5K | 0.01% | 601 |
|
|
2019
Q1 | $26K | Sell |
110
-15
| -12% | -$3.6K | 0.01% | 488 |
|
|
2018
Q4 | $28K | Hold |
125
| – | – | 0.01% | 401 |
|
|
2018
Q3 | $35K | Sell |
125
-18
| -13% | -$5.27K | 0.01% | 412 |
|
|
2018
Q2 | $41K | Hold |
143
| – | – | 0.02% | 357 |
|
|
2018
Q1 | $36K | Sell |
143
-7
| -5% | -$1.64K | 0.01% | 401 |
|
|
2017
Q4 | $32K | Sell |
150
-3
| -2% | -$607 | 0.01% | 447 |
|
|
2017
Q3 | $28K | Sell |
153
-45
| -23% | -$7.85K | 0.02% | 446 |
|
|
2017
Q2 | $34K | Sell |
198
-151
| -43% | -$24.2K | 0.02% | 372 |
|
|
2017
Q1 | $53K | Sell |
349
-21
| -6% | -$3.07K | 0.03% | 250 |
|
|
2016
Q4 | $54K | Sell |
370
-12
| -3% | -$1.74K | 0.03% | 258 |
|
|
2016
Q3 | $48K | Sell |
382
-2
| -0.5% | -$241 | 0.03% | 268 |
|
|
2016
Q2 | $43K | Sell |
384
-4
| -1% | -$415 | 0.03% | 274 |
|
|
2016
Q1 | $40K | Sell |
388
-22
| -5% | -$2.1K | 0.02% | 287 |
|
|
2015
Q4 | $46K | Buy |
+410
| New | +$45.3K | 0.03% | 246 |
|
Other funds holding ICUI
Versant Capital Management's ICUI Position: Q3 2026 in Review
Versant Capital Management increased its ICU Medical (ICUI) stake by 26% in Q3 2026, buying an estimated $10.8K and bringing the position to 313 shares worth $50.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1401.
Versant Capital Management first reported a position in ICUI in Q4 2015 and has held it in 44 quarters since. The position peaked at $115K in Q4 2025. 248 funds tracked by Wall St. Rank hold ICUI as of Q3 2026.
- Versant Capital Management held 313 shares of ICU Medical worth $50.2K as of Q3 2026.
- Versant Capital Management bought 65 ICU Medical shares in Q3 2026, an estimated $10.8K.
- ICU Medical made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #1401 holding.
- Versant Capital Management first reported a position in ICU Medical in Q4 2015 and has held it in 44 quarters since.
- Versant Capital Management's ICU Medical position peaked at $115K in Q4 2025.
- 248 funds tracked by Wall St. Rank held ICU Medical as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.